New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Astellas Pharma Inc.
ALPMY
Shape
US Flag

PNK

EPS improving

EPS improving

20B

Drug Manufacturers - General

Next Earning date - 06 Nov 2024

20B

Drug Manufacturers - General

Next Earning date - 06 Nov 2024

11.45USD
Shape-0.03 ( -0.26%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-97%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

18%

Quote Panel

Shape
Updated October 3, 2024
1W -3.54 % 1M -7.66 % 3M 14.27 % 1Y -13.72 %

Key Metrics

Shape
  • Market Cap

    20.49B


  • Shares Outstanding

    1.79B


  • Share in Float

    1.73B


  • Dividende

    0.46


  • Earning Date

    06 Nov 2024


  • Price Target

    11.45


  • Average Volume

    140323


  • Beta

    0.294


  • Range

    9.15-14.03


  • Industry

    Drug Manufacturers - General


  • Website

    https://www.astellas.com


  • Sector

    Healthcare


Fundamentals

Shape

24.89x

P/E Ratio

1.77x

P/S Ratio

1.80x

P/B Ratio

0.6

Debt/Equity

1.0%

Net Margin

$0.1

EPS

How ALPMY compares to sector?

P/E Ratio

Relative Strength

Shape

ALPMY

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$1716B

Shape263%

2025-Revenue

$33.24

Shape58%

2025-EPS

$420B

Shape305%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Bernstein

upgrade

Previous: Not converted

2024-08-20

Now: Outperform

Jefferies

downgrade

Previous: Buy

2024-07-18

Now: Hold

Citigroup

upgrade

Previous: Not converted

2023-04-16

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+40%

0.28
vs 0.2

Q4.22

arrow
arrow

-21%

0.27
vs 0.34

Q1.23

arrow
arrow

+475%

0.15
vs -0.04

Q2.23

arrow
arrow

+30%

0.13
vs 0.1

Q3.23

arrow
arrow

N/A

-0.01
vs 0.28

Q4.23

arrow
arrow

-56%

0.12
vs 0.27

Q1.24

arrow
arrow

-27%

0.11
vs 0.15

Q2.24

arrow
arrow

+85%

0.24
vs 0.13

Q3.24

arrow
arrow

+160023%

15.99
vs -0.01

Q4.24

arrow
arrow

+14157%

17.11
vs 0.12

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+17%

380.4B  vs 325.5B

Q4.22

arrow
arrow

+18%

402.2B  vs 340.6B

Q1.23

arrow
arrow

+17%

354.3B  vs 303.9B

Q2.23

arrow
arrow

-2%

375B  vs 381.8B

Q3.23

arrow
arrow

+3%

392.1B  vs 380.4B

Q4.23

arrow
arrow

+5%

421.9B  vs 402.2B

Q1.24

arrow
arrow

+17%

414.6B  vs 354.3B

Q2.24

arrow
arrow

+26%

473.1B  vs 375B

Q3.24

arrow
arrow

+8%

423B  vs 392.1B

Q4.24

arrow
arrow

+6%

448B  vs 421.9B

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+4%

0.04
vs 0.02

Q4.22

arrow
arrow

+3%

0.03
vs 0.04

Q1.23

arrow
arrow

-3%

-0.03
vs 0.03

Q2.23

arrow
arrow

+2%

0.02
vs -0.03

Q3.23

arrow
arrow

0%

-0.00
vs 0.02

Q4.23

arrow
arrow

+1%

0.01
vs -0.00

Q1.24

arrow
arrow

-2%

-0.02
vs 0.01

Q2.24

arrow
arrow

+2%

0.02
vs -0.02

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News